Portal de investigación
- Inicio
- Proyectos y Estudios
- ENSAYO CLÍNICO CONTROLADO, ALEATORIZADO, ABIERTO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE MARAVIROC EN SUSTITUCIÓN DE LOS INHIBIDORES ANÁLOGOS NUCLEÓSIDOS O NUCLEÓTIDOS (N(T)RTI) O DE LOS INHIBIDORES DE LA PROTEASA (IP) POTENCIADOS CON RITONAVIR EN PACIENTES CON INFECCIÓN POR VIH-1 Y SUPRESIÓN IROLÓGICA EN SU PRIMER RÉGIMEN CON UNA COMBINACIÓN DE N(T)RTI + IP/R.
ENSAYO CLÍNICO CONTROLADO, ALEATORIZADO, ABIERTO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE MARAVIROC EN SUSTITUCIÓN DE LOS INHIBIDORES ANÁLOGOS NUCLEÓSIDOS O NUCLEÓTIDOS (N(T)RTI) O DE LOS INHIBIDORES DE LA PROTEASA (IP) POTENCIADOS CON RITONAVIR EN PACIENTES CON INFECCIÓN POR VIH-1 Y SUPRESIÓN IROLÓGICA EN SU PRIMER RÉGIMEN CON UNA COMBINACIÓN DE N(T)RTI + IP/R.
Datos básicos
- Código:
- KIRBY-MARCH
- Protocolo:
- KIRBY-MARCH
- EUDRACT:
- 2011-002107-15
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- 2012
- Año de finalización:
- 2015
Objetivos del proyecto
Observaciones: Estado Comité: FINALIZADO. Falta por cobrar la factura EC/8107 de 596,23€
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
[Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus].
Polo Rodríguez R; (...); Martínez Chamorro E
Abstract of Published Item. 10.1016/j.eimc.2014.06.006. 2015
[Epidemiology and prevention of nosocomial invasive infections by filamentous fungi and yeasts].
Abstract of Published Item. 10.1016/j.eimc.2013.02.002. 2013
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains.
Cuervo G; (...); Validation Cohort Project
Article. 10.1016/j.cmi.2015.02.029. 2015
Anidulafungin-Induced Alopecia
Ruiz-Ramos J; (...); Poveda-Andrés JL
Article. 10.1177/1060028014524534. 2014
Association of baseline CD4+cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients
Aldámiz-Echevarría T; (...); Berenguer J
Article. 10.1016/S1665-2681(19)31167-6. 2015
Bloodstream Infections in Adult Patients Undergoing Cord Blood Transplantation from Unrelated Donors after Myeloablative Conditioning Regimen
Article. 10.1016/j.bbmt.2014.12.038. 2015
Boosted protease inhibitor monotherapy in HIV-infected patients: results of a study in a real life setting
Di Benedetto N; (...); Salavert M
Article. 2015
Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma
Blanes M; (...); de la Rubia J
Article. 10.3109/10428194.2014.922182. 2015
Cerebral phaeohyphomycosis: Description of a case and review of the literature
Frasquet-Artés JS; (...); López-Hontangas JL
Review. 10.1016/j.riam.2012.12.008. 2014
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus
Berenguer, Juan; (...); Gonzalez-Garcia, Juan
Article. 10.1016/j.jhep.2013.01.042. 2013
Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus
Berenguer J; (...); González-García J
Article. 10.1093/cid/ciu939. 2015
Control y prevención de las infecciones nosocomiales y asociadas a cuidados sanitarios causadas por especies de Candida y otras levaduras
Pemán J, Zaragoza R, Salavert M.
Article. 2013
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients.
Grau S; (...); Rubio-Terrés C
Article. 10.2147/CEOR.S91587. 2015
Chronic pain and a single lesion in the distal radius
Di Benedetto N; (...); Salavert M
Editorial Material. 10.1016/j.eimc.2014.11.011. 2015
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
Shaw E; (...); Instituto de Salud Carlos III, Madrid, Spain
Article. 10.1136/bmjopen-2014-006723. 2015
Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain
Serrano-Villar, S; (...); CoRIS
Article. 10.1111/jvh.12353. 2015
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
Arribas JR; (...); OLE
Article. 10.1016/S1473-3099(15)00096-1. 2015
EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases
Article. 10.1038/bmt.2013.190. 2014
ECONOMIC EVALUATION OF FIDAXOMICIN FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS (CDI) ALSO KNOWN AS CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHOEA (CDAD) IN SPAIN
Cobo Reinoso J; (...); Rubio-Rodriguez D
Meeting Abstract. 10.1016/j.jval.2014.08.2501. 2014
Effects of Sustained Viral Response in Patients With HIV and Chronic Hepatitis C and Nonadvanced Liver Fibrosis
Berenguer J; (...); González-García J
Article. 10.1097/QAI.0000000000000156. 2014
Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial
Martinez-Atienza, J; (...); Cordero, E
Article. 10.1186/1745-6215-15-338. 2014
Erythrocyte deformability in naïve HIV-infected patients.
Vayá A; (...); Ricart JM
Article. 10.3233/CH-2011-1529. 2012
Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection
Polo Rodríguez R; (...); Martínez Chamorro E
Article. 10.1016/j.eimc.2014.05.018. 2015
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014)
Expert Panel of GeSIDA and the National Aids Plan; (...); Rivero A
Article. 10.1016/j.eimc.2014.02.018. 2014
Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015)
Expert Panel of GESIDA and the National AIDS Plan; (...); Rivero A
Article. 10.1016/j.eimc.2015.03.017. 2015
Feohifomicosis cerebral: Descriptción de un caso y revisión de la literatura
Frasquet-Artés JS; (...); López-Hontangas JL.
Article. 2014
General epidemiology of invasive fungal disease
Peman, Javier, Salavert, Miguel
Article. 10.1016/j.eimc.2011.09.004. 2012
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir.
Rodríguez-Medina B; (...); Berenguer M
Article. 10.1016/S1665-2681(19)31305-5. 2013
How to assist clinicians in improving antimicrobial prescribing: tools and interventions provided by stewardship programs.
López-Medrano F; (...); Salavert M
Article. 10.1016/S0213-005X(13)70131-9. 2013
Immunopathogenesis of invasive mould infections
García-Vidal C, Salavert Lletí M
Review. 10.1016/j.riam.2014.09.001. 2014
Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain.
Merchante N; (...); Pineda JA
Article. 10.1093/cid/cis777. 2013
Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.
Blanes M; (...); de la Rubia J
Article. 10.1016/j.bbmt.2012.08.009. 2013
Invasive fungal disease due to Scedosporium, Fusarium and mucorales
Review. 10.1016/j.riam.2014.05.002. 2014
Invasive infection diseases by filamentous fungi
Ramírez P, Salavert, M, Quindos, G
Editorial Material. 10.1016/j.riam.2014.07.002. 2014
Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.
Mateos MV; (...); San Miguel JF
Article. 10.1056/NEJMoa1300439. 2013
Limbic encephalitis and related cortical syndromes.
Rubio-Agusti I, Salavert M, Bataller L
Article. 10.1007/s11940-012-0212-7. 2013
Lopinavir/ritonavir en pacientes infectados por el virus de la inmunodeficiencia humana en situaciones especiales.
Tasias M, Aldeguer JL
Article. 10.1016/S0213-005X(14)70163-6. 2014
Management of Infection and Febrile Neutropenia in Patients with Solid Cancer
Aguado, JM; (...); Carratala, J
Review. 10.1016/j.eimc.2015.06.005. 2017
Membranous glomerulonephritis and cellular crescents induced by levamisole-adulterated cocaine abuse: a case report.
Roca-Argente L; (...); Hernández-Jaras J
Article. 10.3978/j.issn.2305-5839.2015.10.29. 2015
Mycobacterium genavense Infections in a Tertiary Hospital and Reviewed Cases in Non-HIV Patients.
Santos M; (...); Gobernado M
Article. 10.1155/2014/371370. 2014
Pleuropulmonary angiosarcoma involving the liver, the jejunum and the spine, developed from chronic tuberculosis pyothorax: Multidisciplinary approach and review of literature
Bruixola G; (...); Aparicio J
Review. 10.1016/j.lungcan.2014.07.012. 2014
Prevention and control of nosocomial and health-care facilities associated infections caused by species of Candida and other yeasts.
Pemán J, Zaragoza R, Salavert M
Abstract of Published Item. 2013
Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort
Meije, Y; (...); Gavalda, J
Article. 10.1111/tid.12226. 2014
Primary Central Nervous System Posttransplant Lymphoproliferative Disease in a Bilateral Transfemoral Lower Extremity Transplantation Recipient
Cavadas, PC; (...); Mayordomo-Aranda, E
Article. 10.1111/ajt.13313. 2015
Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient
Barberan, Jose; (...); de la Torre Cisneros, Julian
Article. 2011
Repeated CMV infection in a heart transplantation patient.
Melero-Ferrer J; (...); Salvador-Sanz A
Article. 10.1155/2012/305920. 2012
Reproductive desire in women with HIV infection in Spain, associated factors and motivations: a mixed-method study
Hernando, V; (...); CoRIS
Article. 10.1186/1471-2393-14-194. 2014
Role of autologous bone marrow transplant in multiple myeloma.
Article. 10.1097/CCO.0b013e328358f686. 2012
Safety of anidulafungin in solid organ transplant recipients.
Aguado JM; (...); Montejo M
Article. 10.1002/lt.23410. 2012
Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study
Minguez C; (...); Lopez-Aldeguer J
Meeting Abstract. 10.7448/IAS.17.4.19634. 2014
The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients
Gonzalez EO; (...); Llerena G
Meeting Abstract. 10.7448/IAS.17.4.19643. 2014
The threat of the carbapenemase-producing enterobacteriaceae in Spain: Positioning report of the SEIMC study groups, GEIH and GEMARA
Oteo J; (...); Salavert M
Article. 10.1016/j.eimc.2014.02.011. 2014
Treatment of invasive fungal disease using anidulafungin alone or in combination for hematologic patients with concomitant hepatic or renal impairment
Montesinos P; (...); Sanz MÁ
Article. 10.1016/j.riam.2014.10.003. 2015
Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy.
Berenguer J; (...); Del Amo J
Article. 10.1097/QAD.0b013e3283574e94. 2012
Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes
Monge, S; (...); Del Amo, J
Article. 10.5588/ijtld.13.0778. 2014
Tuberculosis Prophylaxis With Levofloxacin in Liver Transplant Patients Is Associated With a High Incidence of Tenosynovitis: Safety Analysis of a Multicenter Randomized Trial
Torre-Cisneros, J; (...); Aguado, JM
Article. 10.1093/cid/civ156. 2015
Visceral leishmaniasis infection during adalimumab therapy: a case report and literature review
Tung Chen Y; (...); Salavert M
Letter. 10.1111/1756-185X.12427. 2014